We knew these deals with Novo Nordisk and Merck and Pfizer and so ... contract research organization, generating large data assets for customers to order for -- often for AI model training.

Novo Nordisk shares rallied on Tuesday as a maker of a weight-loss drug alternative confirmed it won’t be selling it for much longer. Hims & Hers Health Inc.’s stock plunged last week when the ...

Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our ...

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland ...

Novo Nordisk has filed another Citizen's Petition with the FDA seeking to block compounding pharmacies in the US from making versions of one of its GLP-1 agonist drugs. The latest attempt focuses ...

It has been estimated that 90% of medical device waste consists of single-use products or components, so a new initiative by Novo Nordisk to recycle pre-filled injection pens used by people living ...

Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our ...

Ericsson has decided to consolidate its regional structure, organizing the market areas ... They are strong leaders in Ericsson, each having made an impact on the organization since joining my ...

This increase reflects investor confidence in the company’s strategic initiatives and cost management, despite the revenue shortfall. While the stock remains below its 52-week high of $23.86 but ...

This improvement reflects the company's efforts toward achieving greater operational efficiency and cost management. Following the earnings call, Ginkgo Bioworks' stock price fell by 15.16% in ...